سرم مانیتول مرگ و میر سکته حاد با ورم مغز را افزایش میدهد

Treatment with mannitol is associated with increased risk for in-hospital mortality in patients with acute ischemic stroke and cerebral edema
American Journal of Cardiovascular Drugs — Papagianni M, et al. | June 01, 2018

sponsor

Researchers prospectively assessed the impact of mannitol on the outcome of ischemic stroke-related cerebral edema. Among patients treated with mannitol vs in those who were not, higher rates of dependency were noted. Age, history of ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) score at admission were identified as independent predictors of dependency. Diastolic blood pressure, NIHSS score at admission and treatment with mannitol were identified as independent predictors of in-hospital mortality. Overall, the functional outcome of patients with ischemic stroke-related cerebral edema did not appear to be influenced by treatment with mannitol, and instead, administration of mannitol might increase mortality, independently of stroke severity, in these patients.

این نوشته در دسته‌بندی نشده ارسال و , , برچسب شده است. افزودن پیوند یکتا به علاقه‌مندی‌ها.

پاسخ دهید

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *


6 − = پنج

شما می‌توانید از این دستورات HTML استفاده کنید: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>